TY  - JOUR
AU  - Zuily, Stéphane
AU  - Clerc-Urmès, Isabelle
AU  - Bauman, Cédric
AU  - Andrade, Danieli
AU  - Sciascia, Savino
AU  - Pengo, Vittorio
AU  - Tektonidou, Maria G
AU  - Ugarte, Amaia
AU  - Gerosa, Maria
AU  - Michael Belmont, H
AU  - Zamorano, Maria Angeles Aguirre
AU  - Fortin, Paul
AU  - Ji, Lanlan
AU  - Efthymiou, Maria
AU  - Cohen, Hannah
AU  - Branch, D Ware
AU  - Jesus, Guilherme Ramires de
AU  - Nalli, Cecilia
AU  - Petri, Michelle
AU  - Rodriguez, Esther
AU  - Cervera, Ricard
AU  - Knight, Jason S
AU  - Atsumi, Tatsuya
AU  - Willis, Rohan
AU  - Bertolaccini, Maria Laura
AU  - Vega, Joann
AU  - Wahl, Denis
AU  - Erkan, Doruk
AU  - APS ACTION Investigators
PY  - 2020
DO  - 10.1177/0961203320940776
UR  - https://hdl.handle.net/10668/28219
T2  - Lupus
AB  - This study aimed to use cluster analysis (CA) to identify different clinical phenotypes among antiphospholipid antibodies (aPL)-positive patients. The Alliance for Clinical Trials and International Networking (APS ACTION) Registry includes...
LA  - en
KW  - APS ACTION
KW  - Antiphospholipid syndrome
KW  - cardiovascular risk factors
KW  - systemic lupus erythematosus
KW  - triple positivity
TI  - Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
TY  - research article
VL  - 29
ER  -